Celgene defends patents covering lenalidomide and apremilast before European Patent Office
Clients Celgene Corporation
Jones Day represents Celgene Corporation in defense of patents covering lenalidomide and apremilast against oppositions brought before the European Patent Office by generic pharmaceutical companies.